CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
First line trastuzumab-based therapy in HER2-positive metastatic breast cancer patients (MBC) presenting with de novo or recurrent disease
Authors
A Bernardo
L Del Mastro
+17 more
C Dellepiane
Ar Ferreira
A Fontana
D Grasso
A Lai
M Lambertini
G Minuti
S Mura
F Poggio
E Poletto
P Pronzato
F Puglisi
E Risi
V Sini
F Sottotetti
E Zanardi
S Ziliani
Publication date
1 January 2015
Publisher
place:2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA
Abstract
Abstract is not available.
Similar works
Full text
Available Versions
Archivio istituzionale della ricerca - Università di Genova
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:iris.unige.it:11567/935609
Last time updated on 16/01/2019